Results 61 to 70 of about 1,502,037 (222)

How Proton Incorporation Reshapes Lattice Dynamics In BaSnO3‐Type Proton Conductors

open access: yesAdvanced Science, EarlyView.
Yttrium‐doped BaSnO3 exhibits isotope‐dependent changes in its low‐energy vibrational density of states upon hydration. Comparison of dry, H2O‐, and D2O‐treated samples re‐veals mass‐dependent phonon renormalization linked to proton dynamics near oxygen va‐cancies, providing experimental insight into hydrogen‐coupled lattice excitations in proton ...
Artur Braun   +9 more
wiley   +1 more source

XAFS spectrum of Yttrium oxide [PDF]

open access: yes
This dataset consists of X-ray absorption fine structure (XAFS) spectra at Y K-edge of yttrium oxide measured at Aichi SR BL5S1, and is a part of XAFS database (MDR XAFS DB, https://doi.org/10.48505/nims.1447) as a collection of ...
Aichi SR
core   +1 more source

Non‐Noble Metal Nanocatalysts for Hydrogen Evolution

open access: yesAdvanced Science, EarlyView.
Recent overviews and latest developments of diverse classes of non‐noble catalysts for application toward high‐performance photocatalysis, thermocatalytic steam reforming, and electrocatalysis. Toward sustainability objectives, several advanced characterization tools in combination with the latest breakthroughs in machine learning for material ...
Lina Jaya Diguna   +7 more
wiley   +1 more source

Quantitative and qualitative assessment of Yttrium-90 PET/CT imaging. [PDF]

open access: yesPLoS ONE, 2014
Yttrium-90 is known to have a low positron emission decay of 32 ppm that may allow for personalized dosimetry of liver cancer therapy with (90)Y labeled microspheres.
Ali Asgar Attarwala   +6 more
doaj   +1 more source

Determination of strontium 90 in environmental materials. [PDF]

open access: yes, 1967
A method for determining strontium 90 in environmental materials is described. It consists of the ion-exchange separation of strontium from calcium at an elevated temperature by careful control of pH and the molar ratio of Ca:EDTA, followed by scavenging,
Piper, NR, Davis, PS
core  

Radioembolization Treatment for Liver Cancer

open access: yesBezmiâlem Science, 2016
Although curative treatment is surgery (resection/transplantation) and for small lesions ablative strategies, in primary liver carcinomas such as hepatocellular carcinoma and cholangiocellular carcinoma, palliative treatment is used for most of these ...
Ezgi Başak ERDOĞAN   +2 more
doaj   +1 more source

Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with Y microspheres [PDF]

open access: yesClinical and Molecular Hepatology, 2014
Transcatheter arterial radioembolization (TARE) with Yttrium-90 (90Y)-labeled microspheres has an emerging role in treatment of patients with unresectable hepatocellular carcinoma.
Sun Young Yim   +10 more
doaj   +1 more source

Overcoming Interfacial Hurdles in Solid‐State Aluminum Batteries for Safe and Energy‐Dense Storage

open access: yesAdvanced Science, EarlyView.
Solid‐state aluminum batteries (SSABs) promise high energy density and intrinsic safety but face severe solid–solid interfacial challenges. This review reveals the three core hurdles—anode passivation, cathode contact loss, and electrolyte grain boundary resistance and discusses strategies including artificial interphases, alloying, and composite ...
Yunlei Wang   +5 more
wiley   +1 more source

Exceptional Antimodes in Multi‐Drive Cavity Magnonics

open access: yesAdvanced Electronic Materials, EarlyView.
Driven‐dissipative cavity‐magnonics provides a flexible platform for engineering non‐Hermitian physics such as exceptional points. Here, using a four‐port, three‐mode system with controllable microwave interference, antimodes and coherent perfect extinction (CPE) are realized, enabling active tuning to antimode exceptional points.
Mawgan A. Smith   +4 more
wiley   +1 more source

Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization

open access: yesCase Reports in Oncology
Introduction: Immune thrombocytopenia (ITP) secondary to durvalumab, a programmed cell death ligand 1 inhibitor, is a rare but clinically significant immune-related adverse event.
Maaz Khan Afghan   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy